{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T04:42:59Z","timestamp":1770525779871,"version":"3.49.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","nanomedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1016\/j.nano.2015.02.003","type":"journal-article","created":{"date-parts":[[2015,2,26]],"date-time":"2015-02-26T01:00:36Z","timestamp":1424912436000},"page":"1227-1236","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Toxicity studies of coumarin 6-encapsulated polystyrene nanospheres conjugated with peanut agglutinin and poly(N-vinylacetamide) as a colonoscopic imaging agent in rats"],"prefix":"10.1016","volume":"11","author":[{"given":"Shinji","family":"Sakuma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hironori","family":"Kumagai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moe","family":"Shimosato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tokio","family":"Kitamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kohta","family":"Mohri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuya","family":"Ikejima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken-ichiro","family":"Hiwatari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seiji","family":"Koike","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Etsuo","family":"Tobita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"McClure","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John C.","family":"Gore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wellington","family":"Pham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nano.2015.02.003_bb0005","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.pharmthera.2006.05.006","article-title":"Current state, achievements, and future prospects of polymeric micelles as nanocarriers for drug and gene delivery","volume":"112","author":"Nishiyama","year":"2006","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.nano.2015.02.003_bb0010","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1021\/nn900002m","article-title":"Impact of nanotechnology on drug delivery","volume":"3","author":"Farokhzad","year":"2009","journal-title":"ACS Nano"},{"key":"10.1016\/j.nano.2015.02.003_bb0015","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1016\/j.addr.2009.09.002","article-title":"Micro- and nanotechnologies for intelligent and responsive biomaterial-based medical systems","volume":"61","author":"Caldorera-Moore","year":"2009","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.nano.2015.02.003_bb0020","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1097\/CCO.0000000000000012","article-title":"Update on current and potential nanoparticle cancer therapies","volume":"25","author":"Rink","year":"2013","journal-title":"Curr Opin Oncol"},{"key":"10.1016\/j.nano.2015.02.003_bb0025","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1002\/jps.21179","article-title":"Amphotericin B formulations and drug targeting","volume":"97","author":"Torrado","year":"2008","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.nano.2015.02.003_bb0030","doi-asserted-by":"crossref","first-page":"361","DOI":"10.2165\/00003495-200969030-00010","article-title":"Liposomal amphotericin B: a review of its use as empirical therapy in febrile neutropenia and in the treatment of invasive fungal infections","volume":"69","author":"Moen","year":"2009","journal-title":"Drugs"},{"key":"10.1016\/j.nano.2015.02.003_bb0035","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0168-3659(99)00248-5","article-title":"Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review","volume":"65","author":"Maeda","year":"2000","journal-title":"J Control Release"},{"key":"10.1016\/j.nano.2015.02.003_bb0040","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.addr.2010.05.001","article-title":"EPR effect based drug design and clinical outlook for enhanced cancer chemotherapy","volume":"63","author":"Maeda","year":"2001","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.nano.2015.02.003_bb0045","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jconrel.2012.03.020","article-title":"Doxil\u00ae \u2014 the first FDA-approved nano-drug: lessons learned","volume":"160","author":"Barenholz","year":"2012","journal-title":"J Control Release"},{"key":"10.1016\/j.nano.2015.02.003_bb0050","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.addr.2012.08.009","article-title":"Immunoconjugates and long circulating systems: origins, current state of the art and future directions","volume":"65","author":"Koshkaryev","year":"2013","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.nano.2015.02.003_bb0055","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.ejpb.2008.04.027","article-title":"Poly(N-vinylacetamide) chains enhance lectin-induced biorecognition through the reduction of nonspecific interactions with non-targets","volume":"70","author":"Hiwatari","year":"2008","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.nano.2015.02.003_bb0060","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.jconrel.2008.10.017","article-title":"In vitro\/in vivo biorecognition of lectin-immobilized fluorescent nanospheres for human colorectal cancer cells","volume":"134","author":"Sakuma","year":"2009","journal-title":"J Control Release"},{"key":"10.1016\/j.nano.2015.02.003_bb0065","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.ejpb.2010.01.001","article-title":"Detection of early colorectal cancer imaged with peanut agglutinin-immobilized fluorescent nanospheres having surface poly(N-vinylacetamide) chains","volume":"74","author":"Sakuma","year":"2010","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.nano.2015.02.003_bb0070","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.ejps.2010.12.011","article-title":"A potential of peanut agglutinin-immobilized fluorescent nanospheres as a safe candidate of diagnostic drugs for colonoscopy","volume":"42","author":"Sakuma","year":"2011","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.nano.2015.02.003_bb0075","doi-asserted-by":"crossref","first-page":"367","DOI":"10.2174\/157016311798109407","article-title":"Lectin-immobilized fluorescent nanospheres for targeting to colorectal cancer from a physicochemical perspective","volume":"8","author":"Sakuma","year":"2011","journal-title":"Curr Drug Discov Technol"},{"key":"10.1016\/j.nano.2015.02.003_bb0080","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.ejpb.2011.06.001","article-title":"Essence of affinity and specificity of peanut agglutinin-immobilized fluorescent nanospheres with surface poly(N-vinylacetamide) chains for colorectal cancer","volume":"79","author":"Sakuma","year":"2011","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.nano.2015.02.003_bb0085","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1002\/ijc.27903","article-title":"Multifunctional nanobeacon for imaging Thomsen-Friedenreich antigen-associated colorectal cancer","volume":"132","author":"Kumagai","year":"2013","journal-title":"Int J Cancer"},{"key":"10.1016\/j.nano.2015.02.003_bb0090","doi-asserted-by":"crossref","unstructured":"Kitamura T, Sakuma S, Shimosato M, Higashino H, Masaoka Y, Kataoka M, et al. Specificity of lectin-immobilized fluorescent nanospheres for colorectal tumors in a mouse model which better resembles the clinical disease. Contrast Media Mol Imaging, in press.","DOI":"10.1002\/cmmi.1609"},{"key":"10.1016\/j.nano.2015.02.003_bb0095","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1002\/ijc.29093","article-title":"Fluorescence-based endoscopic imaging of Thomsen-Friedenreich antigen to improve early detection of colorectal cancer","volume":"136","author":"Sakuma","year":"2015","journal-title":"Int J Cancer"},{"key":"10.1016\/j.nano.2015.02.003_bb0100","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1177\/36.10.3138307","article-title":"Quantitation of lectin binding sites in human colon mucins by use of peanut and wheat germ agglutinin","volume":"36","author":"Boland","year":"1988","journal-title":"J Histochem Cytochem"},{"key":"10.1016\/j.nano.2015.02.003_bb0105","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1073\/pnas.79.6.2051","article-title":"Alterations in human colonic mucin occurring with cellular differentiation and malignant transformation","volume":"79","author":"Boland","year":"1982","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.nano.2015.02.003_bb0110","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1146\/annurev.bb.24.060195.003003","article-title":"Lectin structure","volume":"24","author":"Rini","year":"1995","journal-title":"Annu Rev Biophys Biomol Struct"},{"key":"10.1016\/j.nano.2015.02.003_bb0115","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0378-5173(98)00346-9","article-title":"Mucoadhesion of polystyrene nanoparticles having surface hydrophilic polymeric chains in the gastrointestinal tract","volume":"177","author":"Sakuma","year":"1999","journal-title":"Int J Pharm"},{"key":"10.1016\/j.nano.2015.02.003_bb0120","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0169-409X(00)00119-8","article-title":"Design of nanoparticles composed of graft copolymers for oral peptide delivery","volume":"47","author":"Sakuma","year":"2001","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.nano.2015.02.003_bb0125","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0168-3659(02)00072-X","article-title":"Behavior of mucoadhesive nanoparticles having hydrophilic polymeric chains in the intestine","volume":"81","author":"Sakuma","year":"2002","journal-title":"J Control Release"},{"key":"10.1016\/j.nano.2015.02.003_bb0130","doi-asserted-by":"crossref","first-page":"625","DOI":"10.2165\/00002018-200932080-00002","article-title":"Do nanomedicines require novel safety assessments to ensure their safety for long-term human use?","volume":"32","author":"Hoet","year":"2009","journal-title":"Drug Saf"},{"key":"10.1016\/j.nano.2015.02.003_bb0135","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1002\/jat.1609","article-title":"Nanotechnology and human health: risks and benefits","volume":"30","author":"Cattaneo","year":"2010","journal-title":"J Appl Toxicol"},{"key":"10.1016\/j.nano.2015.02.003_bb0140","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.jconrel.2012.01.027","article-title":"Safety assessment of nanomaterials: implications for nanomedicine","volume":"161","author":"Nystr\u00f6m","year":"2012","journal-title":"J Control Release"},{"key":"10.1016\/j.nano.2015.02.003_bb0145","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1002\/bjs.6127","article-title":"Management of early rectal cancer","volume":"95","author":"Tytherleigh","year":"2008","journal-title":"Br J Surg"},{"key":"10.1016\/j.nano.2015.02.003_bb0150","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3322\/caac.21166","article-title":"Cancer statistics, 2013","volume":"63","author":"Siegel","year":"2013","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.nano.2015.02.003_bb0155","doi-asserted-by":"crossref","first-page":"217","DOI":"10.7150\/jca.5829","article-title":"Colonoscopy for colorectal cancer screening","volume":"4","author":"Young","year":"2013","journal-title":"J Cancer"},{"key":"10.1016\/j.nano.2015.02.003_bb0160","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.3748\/wjg.v16.i14.1727","article-title":"Effectiveness of narrow-band imaging magnification for invasion depth in early colorectal cancer","volume":"16","author":"Fukuzawa","year":"2010","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.nano.2015.02.003_bb0165","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/nm1692","article-title":"Detection of colonic dysplasia in vivo using a targeted heptapeptide and confocal microendoscopy","volume":"14","author":"Hsiung","year":"2008","journal-title":"Nat Med"},{"key":"10.1016\/j.nano.2015.02.003_bb0170","unstructured":"Guidance on nonclinical safety studies for the conduct of human clinical trials and marketing authorization for pharmaceuticals M3(R2), Current step 4 version dated on 11 June 2009, page 11, ICH Harmonized Tripartite Guideline."}],"container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963415000490?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963415000490?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,24]],"date-time":"2018-09-24T21:28:36Z","timestamp":1537824516000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1549963415000490"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":34,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["S1549963415000490"],"URL":"https:\/\/doi.org\/10.1016\/j.nano.2015.02.003","relation":{},"ISSN":["1549-9634"],"issn-type":[{"value":"1549-9634","type":"print"}],"subject":[],"published":{"date-parts":[[2015,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Toxicity studies of coumarin 6-encapsulated polystyrene nanospheres conjugated with peanut agglutinin and poly(N-vinylacetamide) as a colonoscopic imaging agent in rats","name":"articletitle","label":"Article Title"},{"value":"Nanomedicine: Nanotechnology, Biology and Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nano.2015.02.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}